Pamela Farrell

Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)

Betty Lam, Yasuyoshi Arikawa, Joshua Cramlett et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 60 citations · Full text

Biochemistry, Available Investigational Inhibitor, Medicine +7

Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor

Pamela Farrell, Lihong Shi, Jennifer Matuszkiewicz et al. · Molecular Cancer Therapeutics · 2013 · 44 citations · Full text

Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2

Christopher M. McBride, Zacharia S. Cheruvallath, Mallareddy Komandla et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 24 citations · Full text

Drug Target, Engineering, Drug Design +9

The Use of Therapeutic Listening with Preschoolers with Developmental Disabilities: A Look at the Outcomes

Susan Bazyk, Janet Cimino, Kim Hayes et al. · Journal of Occupational Therapy Schools & Early Intervention · 2010 · 20 citations

Language Development, Pediatric Rehabilitation, Atypical Language Development +25

Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1

Zacharia S. Cheruvallath, Mingnam Tang, Christopher M. McBride et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 16 citations · Full text

Drug Target, Engineering, Drug Design +9